Intellectual Property Licensing
•217 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (217)
| Company | Market Cap | Price |
|---|---|---|
|
GTCH
GBT Technologies Inc.
GTCH monetizes IP via licensing, including VisionWave patents; direct IP licensing activity.
|
$3.70M |
$0.00
|
|
QNRX
Quoin Pharmaceuticals, Ltd.
Company has options to license QRX007 and QRX008; IP licensing is part of its business strategy.
|
$3.05M |
$10.76
-43.10%
|
|
HOFV
Hall of Fame Resort & Entertainment Company
Licensing of Pro Football Hall of Fame IP; core brand/IP licensing activity.
|
$2.88M |
$0.43
|
|
ADN
Advent Technologies Holdings, Inc.
Intellectual Property Licensing is a primary revenue/strategic focus for Advent (licensing IP for MEA technology).
|
$2.45M |
$0.91
-0.65%
|
|
CARM
Carisma Therapeutics, Inc.
Strategic monetization through IP licensing/asset licensing aligns with intellectual property licensing themes.
|
$2.21M |
$0.15
+214.43%
|
|
ENVB
Enveric Biosciences, Inc.
Enveric out-licenses non-core assets and IP, indicating active IP licensing activity.
|
$1.84M |
$6.22
+1.80%
|
|
ELVG
Elvictor Group, Inc.
Licensing of AI software/IP related to the crew management platform.
|
$1.55M |
$0.02
|
|
BNRG
Brenmiller Energy Ltd
Notes potential licensing of proprietary IP and recurring licensing revenues, i.e., Intellectual Property Licensing.
|
$1.37M |
$1.16
+2.21%
|
|
HSTA
Hestia Insight Inc.
Non-binding NSAT-based IP licensing arrangements indicate IP licensing activity.
|
$1.37M |
$0.05
|
|
VYST
Vystar Corporation
Vytex licensing represents a core revenue stream from licensing intellectual property.
|
$1.30M |
$0.06
|
|
CBDY
Target Group Inc.
Ownership/licensing of proprietary genetics from Serious Seeds; IP licensing.
|
$1.11M |
$0.00
|
|
GCLWW
GCL Global Holdings Ltd Warrants
Monetization of owned game IP via IP licensing to third parties in transmedia contexts.
|
$986700 |
$0.06
|
|
CDT
CDT Equity Inc.
Business model centers on licensing/owning IP; assets licensed from AstraZeneca with patent activity.
|
$685128 |
$1.86
+2.20%
|
|
RGBP
Regen BioPharma, Inc.
Revenue is generated from licensing IP to related parties; Intellectual Property Licensing is a direct business activity.
|
$302925 |
$0.01
|
|
YYAI
AiRWA Inc.
YYAI licenses its AI/matchmaking patents and intellectual property to customers, a direct IP licensing model.
|
$302911 |
$1.04
|
|
SCRH
Scores Holding Company, Inc.
Licensing of intellectual property (Scores trademark) to licensees, a core IP licensing activity.
|
$16519 |
$0.00
|
|
NCNA
NuCana plc
NuCana engages in license/collaboration agreements around its ProTide IP, indicating Intellectual Property Licensing as part of its business.
|
N/A |
$4.46
+0.79%
|
Showing page 3 of 3 (217 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
